Drug fiasco highlights need for more openness.
Pollard
Tom
T
D000068579:Celecoxib; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007783:Lactones; D011358:Product Surveillance, Postmarketing / Q000191:economics / Q000639:trends*; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; D006113:United Kingdom
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib